San Diego, CA -- (SBWIRE) -- 05/15/2013 -- A current investor, who holds NASDAQ:STSI shares, filed a lawsuit against certain directors of Star Scientific, Inc. over alleged breaches of fiduciary duties in connection with certain statements.

Investors who are current long term stockholder in shares of Star Scientific, Inc. (NASDAQ:STSI), including those who purchased their NASDAQ:STSI shares prior to 2007 and currently hold any of those share, have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The lawsuit by a current investor against Star Scientific directors over alleged breaches of fiduciary duties follows recently filed lawsuits against Star Scientific, Inc. over alleged Securities Laws Violations. According to that complaint filed the plaintiff alleges that Star Scientific, Inc. violated the Securities Exchange Act of 1934.More specifically, the plaintiff alleges that Defendants allegedly made false and/or misleading statements and/or failed to disclose that Star Scientific, Inc. engaged in potentially illegal transactions involving certain private placements and related party transactions since 2006 involving Star Scientific, Inc. securities.

On January 23, 2012, a report was published that alleged that Star Scientific, Inc. misled investors about the involvement of Johns Hopkins University in the clinical testing of the company's retail nutritional supplement anatabine.

On Jan 28, 2013, Star Scientific, Inc. commented on the report from January 23, 2013. Star Scientific, Inc. said that the report contained numerous false and misleading statements regarding the Company's anatabine research and the initial results of the ASAP Human Thyroid Health Study released by Star Scientific on January 7, 2013.

In January and February 2013 Star Scientific, Inc. received subpoenas from the US Attorney's office investigating transactions in Star Scientific’s securities, including related party transactions, dating back to 2006. On March 18, 2013, Star Scientific, Inc. disclosed this investigation to investors, announcing that the Company and its directors had received subpoenas from the US Attorney's office. The Company also announced that it was conducting an internal investigation regarding these transactions.

Shares of Star Scientific, Inc. (NASDAQ:STSI) declined from $2.95 per share in early January 2013 to as low as $1.26 on April 3, 2013.

On May 14, 2013, NASDAQ:STSI shares closed at $1.31 per share, which is significantly below its current 52 week High of $5.05 per share.

Those who are current long term investors in Star Scientific, Inc. (NASDAQ:STSI) shares, have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com